Search results for "sant"

showing 10 items of 2727 documents

Associations in physical activity and sedentary behaviour among the immigrant and non-immigrant US population

2020

BackgroundImmigrants are at a higher risk of poor mental and physical health. Regular participation in physical activity (PA) and low levels of sedentary time are beneficial for both these aspects of health. The aim was to investigate levels and trends in domain-specific PA and sedentary behaviour in the US. immigrant compared with non-immigrant populations.MethodsFrom the 2007–2016 National Health and Nutrition Examination Survey (NHANES), a total of 25 142 adults (≥18 years) were included in this analysis. PA and sedentary behaviour time were assessed by a questionnaire.ResultsTransit-related PA showed downward linear trends in young immigrant adults (ptrend=0.006) and middle-aged non-imm…

AdultMaleAdolescent*ImmigrationNational Health and Nutrition Examination SurveyEpidemiologymedia_common.quotation_subjectHealth BehaviorImmigrationPopulationPhysical activityphysical activityEmigrants and ImmigrantsImmigration030209 endocrinology & metabolismMotor ActivitySittingYoung Adult*NHANES03 medical and health sciencesLeisure Activities0302 clinical medicineAge groupsSurveys and Questionnairessedentary behaviourNHANESHumansMedicine030212 general & internal medicineeducationExerciseAgedmedia_commonSedentary timeSedentaryeducation.field_of_studybusiness.industryPublic Health Environmental and Occupational HealthPhysical healthMiddle AgedNutrition SurveysUnited States*Physical activity*Sedentary[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieFemaleSedentary BehaviorbusinessDemographyJournal of Epidemiology and Community Health
researchProduct

Alliesthesia is greater for odors of fatty foods than of non-fat foods

2011

International audience; Alliesthesia is the modulation of the rewarding value of a stimulus according to the internal state (hungry or satiated). This study aimed to evaluate this phenomenon as a function of the nature of the stimulus (odors evoking edible and non-edible items, and the food odors evoking fatty and non-fat foods) and to compare the effectiveness of two reward evaluations (measures of pleasantness and appetence) to reveal alliesthesia. The results showed that both fatty and non-fat food odors were judged as less pleasant and less appetent when the subjects were satiated than when they were hungry, whereas no such difference was observed for non-food odors. There was a greater…

AdultMaleAdolescentgenetic structuresHungerodorFatty foodsAppetiteSatiationStimulus (physiology)AlliesthesiaBody Mass IndexDevelopmental psychologyalliesthesiapleasantnessFood PreferencesYoung AdultAlliesthesia Fat Pleasantness Appetence Odor Internal state03 medical and health sciencesSex Factors0302 clinical medicinefatHumans0501 psychology and cognitive sciences050102 behavioral science & comparative psychologyFood scienceGeneral PsychologyNutrition and Dieteticsmusculoskeletal neural and ocular physiologydigestive oral and skin physiology05 social sciencesbehavioral sciencesDietary FatsSmell[SDV.AEN] Life Sciences [q-bio]/Food and Nutritioninternal stateOdorFoodTasteOdorantsLinear ModelsappetenceFemalePsychology[SDV.AEN]Life Sciences [q-bio]/Food and NutritionFood Analysispsychological phenomena and processes030217 neurology & neurosurgeryAppetite
researchProduct

Roxindole, a dopamine autoreceptor agonist, in the treatment of major depression

1993

Roxindole is a potent autoreceptor-“selective” dopamine agonist originally developed for the treatment of schizophrenic syndromes. The drug also inhibits 5-HT uptake and has 5-HT1A agonistic actions. In this open clinical trial 12 in-patients suffering from a major depressive episode (DSM-III-R) were treated with roxindole for 28 days in a fixed dosage of 15 mg per day. A reduction of at least 50% in HAMD-17 total scores was observed in 8 out of 12 patients after 4 weeks (mean HAMD-17 reduction of 56% in all patients), while 4 patients did not respond to roxindole treatment. Half of the patients showed a complete psychopathological remission (HAMD-17 <8). Roxindole's onset of antidepressant…

AdultMaleAgonistIndolesPyridinesmedicine.drug_classPharmacologyDopamine agonistAsymptomaticchemistry.chemical_compoundRoxindoleDopaminemedicineHumansPharmacology (medical)Major depressive episodePsychiatric Status Rating ScalesPharmacologyDepressive Disorderbusiness.industryMiddle AgedOxindolesProlactinchemistryDopamine receptorAnesthesiaDopamine AgonistsAutoreceptorAntidepressantFemaleNeurology (clinical)medicine.symptombusinessPsychologymedicine.drugPsychopharmacology
researchProduct

Acute Alcohol Effects on Neuronal and Attentional Processing: Striatal Reward System and Inhibitory Sensory Interactions under Acute Ethanol Challenge

2004

The acute influence of ethanol on cerebral activity induces complex psycho-physiological effects that are considerably more pronounced during acute ethanol influx than during maximal blood alcohol concentration (elimination phase). Despite the psychiatric and forensic relevance of these different ethanol effects, the underlying neuronal mechanisms are still unclear. In total, 20 male healthy volunteers were investigated each with three different experimental conditions in a randomized order using an intravenous ethanol challenge (40 g bolus infusion): during influx phase, elimination phase, and under placebo condition. During and after the ethanol (or placebo) infusion, neuropsychological t…

AdultMaleCentral nervous systemSensory systemStriatumNeuropsychological TestsPlaceboRewardFluorodeoxyglucose F18Cortex (anatomy)Image Processing Computer-AssistedmedicineHumansAttentionSingle-Blind MethodSensory cortexBrain ChemistryNeuronsPharmacologyTemporal cortexEthanolCentral Nervous System DepressantsReciprocal inhibitionNeostriatumPsychiatry and Mental healthGlucosemedicine.anatomical_structurePsychologyNeuroscienceTomography Emission-ComputedNeuropsychopharmacology
researchProduct

Latency of interictal epileptiform discharges in long-term EEG recordings in epilepsy patients.

2015

AbstractPurposeTo assess the latency of interictal epileptiform discharges (IED) and seizures in long-term EEG recordings of patients with epilepsy.MethodIED latency was measured in 210 consecutive patients (mean (SD) age 38.6±13.9 years) with active epilepsy and the relationship to clinical variables was analyzed retrospectively. Median duration of EEG recording was 101.5h (95% confidence interval [CI] 92 to 117h).ResultsIEDs were absent in 45 (21.4%) and present in 165 (78.6%) patients who had a longer duration (p<0.001) and early onset (p<0.01) of epilepsy and more often had IEDs in prior standard EEGs (p<0.01), a structural etiology (OR 2.4, CI: 2.1–2.7), or temporal lobe epilepsy (OR 9…

AdultMaleClinical variablesTime FactorsClinical NeurologyVideo RecordingElectroencephalographyEeg recordingEpilepsySeizuresMedicineHumansIctalLatency (engineering)Negative studiesRetrospective StudiesLong-term EEGEpilepsymedicine.diagnostic_testbusiness.industryBrainElectroencephalographyGeneral MedicineInterictal epileptiform dischargesmedicine.diseaseConfidence intervalNeurologyAnesthesiaLatencyAnticonvulsantsFemaleNeurology (clinical)businessSeizure
researchProduct

Inhibition of antidepressant demethylation and hydroxylation by fluvoxamine in depressed patients.

1993

Bidirectional drug interactions between fluvoxamine and classical antidepressants were studied in depressed patients. A column switching technique combined with high performance liquid chromatography (HPLC) enabled automated analyses of plasma for simultaneous determination of fluvoxamine, tricyclic and tetracyclic antidepressants and demethylated and major hydroxylated metabolites in a single HPLC run. The measurements revealed that fluvoxamine inhibited N-demethylation of imipramine, clomipramine, amitriptyline and maprotiline whereas interferences with hydroxylation reactions were restricted to aromatic 8-hydroxylation of clomipramine. In patients under fluvoxamine monotherapy before com…

AdultMaleClomipraminemedicine.drug_classTricyclic antidepressantFluvoxaminePharmacologyHydroxylationImipraminemedicineHumansAmitriptylineMaprotilineChromatography High Pressure LiquidPharmacologychemistry.chemical_classificationDepressive DisorderChemistryMiddle AgedAntidepressive AgentsDealkylationFluvoxamineAntidepressantFemaleSpectrophotometry Ultravioletmedicine.drugTricyclicPsychopharmacology
researchProduct

Identification of resources and skills developed by partners of patients with advanced colon cancer: a qualitative study

2018

National audience; Les aidants familiaux jouent un rôle central auprès des patients présentant un cancer de stade avancé. Parmi les proches susceptibles d’apporter une aide aux personnes malades, les conjoints, en raison des liens qui les unissent et parce qu’ils partagent leur vie quotidienne, sont sans doute les plus confrontés à la maladie. Ils sont également majoritairement désignés comme étant l’aidant principal. L’irruption de la maladie et le besoin d’accompagnement qu’elle nécessite, viennent bouleverser en profondeur les différents équilibres structurant leur quotidien et leur organisation. Ils viennent aussi questionner la nature des relations qu’ils entretiennent, dans une divers…

AdultMaleColorectal cancerHealth PersonnelEmotions[SHS.PSY]Humanities and Social Sciences/Psychology[SDV.CAN]Life Sciences [q-bio]/Cancer[SHS.PSY] Humanities and Social Sciences/Psychology03 medical and health sciences0302 clinical medicineNursingMedicineHumans030212 general & internal medicineQualitative ResearchCancer[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyFamily caregiversbusiness.industryNursing researchSkillsFocus GroupsMiddle Agedmedicine.diseaseFocus groupAdvanced cancer3. Good healthIdentification (information)Cross-Sectional StudiesOncologyCaregivers[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie030220 oncology & carcinogenesisColonic NeoplasmsHealth Resources[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieFemaleClinical CompetenceFranceDependantbusinessQualitative[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyQualitative research
researchProduct

Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)

2021

In randomized controlled trials, add-on brivaracetam (BRV) reduced seizure frequency in patients with drug-resistant focal epilepsy. Studies performed in a naturalistic setting are a useful complement to characterize the drug profile.This multicentre study assessed the effectiveness and tolerability of adjunctive BRV in a large population of patients with focal epilepsy in the context of real-world clinical practice.The BRIVAFIRST (BRIVAracetam add-on First Italian netwoRk STudy) was a retrospective, multicentre study including adult patients prescribed adjunctive BRV. Patients with focal epilepsy and 12-month follow-up were considered. Main outcomes included the rates of seizure-freedom, s…

AdultMaleDrug Resistant EpilepsyLevetiracetamEpilepsy CNS therapyCorrectionMiddle AgedSettore MED/26PyrrolidinonesPsychiatry and Mental healthTreatment OutcomeItalyChemotherapy AdjuvantHumansPharmacology (medical)AnticonvulsantsFemaleNeurology (clinical)Epilepsies PartialRetrospective Studies
researchProduct

Effectiveness of eslicarbazepine acetate in dependency of baseline anticonvulsant therapy: Results from a German prospective multicenter clinical pra…

2019

Abstract Eslicarbazepine acetate (ESL) is a third-generation antiepileptic drug (AED) approved as monotherapy for partial-onset seizures in adults and as adjunctive therapy in patients aged above 6 years in the European Union (EU). The prospective observational Zebinix Effects in DEpendency of BAseline Conditions (ZEDEBAC) study aimed at investigating the effectiveness of ESL in clinical practice, with ESL being administered as monotherapy (mono group), as only add-on to a current monotherapy (1 + group), or as add-on to ≥ 2 baseline AEDs (≥ 2 + group). In total, 237 patients were included, 35 in the mono group, 114 in the 1 +, and 88 in the ≥ 2 + group. Six-month retention rates were 93.9%…

AdultMaleDrug Resistant Epilepsymedicine.medical_specialtyYoung Adult03 medical and health sciencesBehavioral NeuroscienceEpilepsy0302 clinical medicineSodium channel blockerRefractoryDibenzazepinesSeizuresInternal medicineHumansMedicinemedia_common.cataloged_instanceProspective Studies030212 general & internal medicineEuropean unionAgedmedia_commonbusiness.industryMiddle Agedmedicine.diseaseNeurologyEslicarbazepine acetateConcomitantAnticonvulsantsFemaleObservational studyNeurology (clinical)businessHyponatremia030217 neurology & neurosurgerySodium Channel Blockersmedicine.drugEpilepsy &amp; Behavior
researchProduct

Subchronic Antidepressant Treatment with Venlafaxine or Imipramine and Effects on Blood Pressure and Heart Rate: Assessment by Automatic 24-Hour Moni…

1996

Venlafaxine is a new nontricyclic antidepressant inhibiting the reuptake of serotonin, noradrenaline, and, to a lesser extent, dopamine without antagonizing cholinergic, histaminergic, or noradrenergic receptors. Significantly, in a first placebo-controlled safety and efficacy study, high doses of venlafaxine increased blood pressure in some study subjects. In order to investigate further the effect of subchronic antidepressant drug treatment on blood pressure and heart rate, the effects of a conventional tricyclic (imipramine) and a structurally different phenethylamine antidepressant (venlafaxine) were compared. Sixteen inpatients with major depression (melancholic type) were treated for …

AdultMaleImipramineVenlafaxine HydrochlorideHemodynamicsBlood PressureVenlafaxineAntidepressive Agents TricyclicImipramineDouble-Blind MethodHeart RateHeart ratemedicineHumansPharmacology (medical)Psychiatric Status Rating ScalesDepressive Disorderbusiness.industryVenlafaxine HydrochlorideGeneral MedicineBlood Pressure Monitoring AmbulatoryMiddle AgedCyclohexanolsPsychiatry and Mental healthBlood pressureAnesthesiaCirculatory systemAntidepressive Agents Second-GenerationAntidepressantFemalebusinessmedicine.drugPharmacopsychiatry
researchProduct